- Mr. Sam Sun has moved from Quintiles Shanghai to be the
National Sales Manager of Aventis Pasteur
- Ms. LI Ye has been appointed Government Affairs Manager at
Behringer Ingelheim; Ms. LI was previously with GSK Shanghai
- Mr. Jackie Guan has been appointed as the OTC Business Director
at AstraZeneca; Mr. Guan was previously with Schering-Plough Shanghai
- Mr. Jean-Marc Barial, General Manager, Galderma China, has
recently been recalled to France from Beijing
- Mr. Christian Grapow has recently taken up his position as the
Managing Director of Solvay Pharmaceuticals in Shanghai
- Mr. Helmut Leuchten has been appointed as the Chairman and CEO
of Behringher Ingelheim Shanghai; the previous President & CEO, Mr.
Peter Bohenkamp has retired
- Mr. William Keller, until recently the General Manager of
Shanghai Roche, elected to stay in Shanghai and has opened his own
consulting firm for the pharmaceutical industry
- Mr. Roy Gao, previously the HR Director for Shanghai Squibb,
has joined ProHR International as a Partner
- Mr. Peter Wu, recently Country President China for Pharmacia,
has elected to remain as a private businessman in Shanghai and Taiwan, as
a result of the acquisition of Pharmacia by Pfizer
- Dr. Jean-Denis Shu has moved from Aventis Pasteur to become the
Executive Manager for North Asia for vaccines Chiron Behring
- Ms. Bridget Wang, previously a Consultant at Sterling, a
recruitment firm based in Shanghai, has moved to Euro-search, another
executive search firm
- Mr. Alfred Shum, Chairman & CEO of Onpress International,
has recently been elected to the Executive Committee of the Australian
Chamber of Commerce in Shanghai
- Mr. Philip Lu has been appointed to be the General Manager of
GSKĄ¯ s vaccine business
- Professor Pan Aihua has returned to Beijing Weiming to become
the Chairman, and has relinquished all executive responsibilities at
Shenzhen Kexing
- Mr. James Lee, previously of Shanghai Roche, has joined
Sanofi-Synthelabo-Minsheng as the National Sales Director
EditorĄ¯s note: Please send any news and
views to Alfred Shum at the following address:
ashum@onpressint.com
|